Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Humoral and T-cell responses following MVA-BN booster vaccination against mpox virus clades Ib and IIb

25 Aug 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacillus and Francisella bacterial research
Share to Poxvirus research and outbreaks
Share to Virology and Viral Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40865734
DOI: 10.1016/j.jinf.2025.106602

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Humoral and T-cell responses following MVA-BN booster vaccination against mpox virus clades Ib and IIbPMID 40865734Read ↗

Monkeypox virus-neutralising antibodies detected against Clade Ib and Clade IIb in healthy individuals following MVA-BN vaccinationSemantic proximity Read ↗

Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpoxSemantic proximity Read ↗

Single-dose Efficacy of a Next-Generation Mpox Vaccine Harnessing an Immunomodulatory PeptideSemantic proximity Read ↗

Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidateSemantic proximity Read ↗

A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus diseaseSemantic proximity Read ↗

Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDVSemantic proximity Read ↗

Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.Semantic proximity Read ↗

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virusSemantic proximity Read ↗

Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccinationSemantic proximity Read ↗

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infectionSemantic proximity Read ↗

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in SwedenSemantic proximity Read ↗

TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.